Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AiCuris GmbH & Co. KG
DescriptionNon-nucleosidic inhibitor against HBV
Molecular Target
Mechanism of ActionNon-nucleoside polymerase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat hepatitis B virus (HBV) infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today